OKYO Pharma (OKYO) Prepaid Assets (2023 - 2025)
OKYO Pharma (OKYO) reported Prepaid Assets of $394367.0 for Q3 2025, up 23.46% year-over-year from $319437.0 in Q3 2024, and up 74.99% quarter-over-quarter from $225360.0 in Q1 2025.
OKYO Pharma (OKYO) Prepaid Assets (2023 - 2025) Analysis & Trends
OKYO Pharma (OKYO) has 3 years of Prepaid Assets data on file, last reported at $394367.0 in Q3 2025.
- Prepaid Assets for Q3 2025 came in at $394367.0, up 23.46% year-over-year; the trailing twelve-month figure through Sep 2025 was $394367.0 (up 23.46% YoY), and the FY2025 annual result was $225360.0, up 73.19% from the prior year.
- Prepaid Assets advanced to $394367.0 in Q3 2025 per OKYO's latest filing, from $225360.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $394367.0 in Q3 2025 and troughed at $130126.0 in Q1 2024.
- A 3-year average of $264567.6 and a median of $253548.0 in 2023 frame the typical range for Prepaid Assets.
- On a YoY basis, Prepaid Assets climbed as much as 73.19% in 2025 and fell as far as 23.46% in 2025.
- A 3-year view of Prepaid Assets shows it stood at $253548.0 in 2023, then rose by 25.99% to $319437.0 in 2024, then climbed by 23.46% to $394367.0 in 2025.
- Business Quant data shows OKYO's Prepaid Assets at $394367.0 in Q3 2025, $225360.0 in Q1 2025, and $319437.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | OKYO Pharma | 244.98 Mn | 240.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 394,367.00 |
| Mar 31, 2025 | 225,360.00 |
| Sep 30, 2024 | 319,437.00 |
| Mar 31, 2024 | 130,126.00 |
| Sep 30, 2023 | 253,548.00 |